Scripps Research Scientists Receive Up to $12M to Create Universal Vaccine for Alphaviruses
December 05, 2024
December 05, 2024
LA JOLLA, California, Dec. 5 (TNSres) -- The Scripps Research Institute issued the following news:
* * *
Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
* * *
Alphaviruses often cause a range of illnesses that lead to fever, rash and debilitating joint pain. While they're historically prevalent in tropical and subtropical regions of the world where virus-transmitting mosquitos . . .
* * *
Funding from ARPA-H will be used to develop a vaccine for alphaviruses in preparation of major outbreaks in the U.S.
* * *
Alphaviruses often cause a range of illnesses that lead to fever, rash and debilitating joint pain. While they're historically prevalent in tropical and subtropical regions of the world where virus-transmitting mosquitos . . .